AGTR1 and hypertensive disorder: It has been discovered that plasma circulating miRNA-155 can reduce the pro-inflammatory activity of AT1R, thereby reducing the inflammatory/oxidative response, hypertension, endothelial dysfunction, and vascular remodeling [5,30].